Brief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
13/11/2024 13:04
Nov 13 (Reuters) - Nasdaq Inc NDAQ.O :
* NRX PHARMACEUTICALS, INC. (NASDAQ:NRXP) RESCHEDULES
CONFERENCE
CALL TO DISCUSS THIRD QUARTER AND YEAR TO DATE 2024 FINANCIAL
RESULTS TO NOVEMBER 18, 2024
Source text: ID:nPn4y3LCBa
Further company coverage: NDAQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview